Showing results (121-130 of 189) with videos related to
Sort By:
Pageof 19
Synapse (New York, N.Y.)|January 1, 1988
Hormonal regulation of somatostatin messenger RNAF Baldino, S Fitzpatrick-McElligott, T M O'Kane, et al.Cell and Tissue Research|May 1, 1988
Localization of vasopressin-, vasoactive intestinal polypeptide-, peptide histidine isoleucine- and somatostatin-mRNA in rat suprachiasmatic nucleusJ P Card, S Fitzpatrick-McElligott, I Gozes, et al.Journal of Molecular Neuroscience : MN|January 1, 1989
Localization of VIP and PHI-27 messenger RNA in rat thalamic and cortical neuronsF Baldino, S Fitzpatrick-McElligott, I Gozes, et al.Peptides|March 1, 1984
Studies toward the biosynthesis of vasoactive intestinal peptide (VIP)I Gozes, M Bodner, H Shwartz, et al.Molecular Psychiatry|January 25, 2017
ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathyY Ivashko-Pachima, C Laura Sayas, A Malishkevich, et al.Brain Research|December 1, 1982
Conditioned media from activated lymphocytes maintain sympathetic neurons in cultureY Gozes, M A Moskowitz, T B Strom, et al.Neuroscience|October 1, 1992
Distribution of cells expressing vasoactive intestinal peptide/peptide histidine isoleucine-amide precursor messenger RNA in the rat brainM Dussaillant, A Sarrieau, I Gozes, et al.Endocrinology|May 1, 1994
Stearyl-norleucine-vasoactive intestinal peptide (VIP): a novel VIP analog for noninvasive impotence treatmentI Gozes, A Reshef, D Salah, et al.Biochemical and Biophysical Research Communications|November 27, 1985
High levels of vasoactive intestinal peptide in human milkH Werner, Y Koch, M Fridkin, et al.Advances in Neuroimmunology|January 1, 1994
gp120 as an etiologic agent for NeuroAIDS: neurotoxicity and model systemsD E Brenneman, S K McCune, R F Mervis, et al.Pageof 19